TOB1 and prostate adenocarcinoma: For example, TOB1 predicted the prognosis in KIRC, LGG, MESO, PAAD, PCPG, PRAD, SARC, UCEC and UVM patients, and TOB2 predicted poor prognosis in COAD, GBM, KIRC, LGG, PAAD patients.